SuperworthSilo Pharma shares outstanding SILO
Diluted shares outstanding, averaged over each quarter, from 2011.
- Latest quarter, to Jun 30, 2026
- 1.1M
- On a year earlier
- +162.4%
- more shares
Silo Pharma had 1.1M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is 162.4% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 888.3K | +197% |
| FY2024 | 299K | +55% |
| FY2023 | 193.4K | −8% |
| FY2022 | 211.1K | +60% |
| FY2021 | 131.5K | +16% |
| FY2020 | 113.5K | +262% |
| FY2019 | 31.4K | −49% |
| FY2018 | 61.6K | +51% |
| FY2012 | 40.8K | +0% |
| FY2011 | 40.8K | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 1.1M | +162% | |
| Q1 FY26 | 913.9K | +206% | |
| Q4 FY25 | 888.3K | +197% | |
| Q3 FY25 | 622.1K | +117% | |
| Q2 FY25 | 418.6K | +106% | |
| Q1 FY25 | 299K | +56% | |
| Q4 FY24 | 299K | +55% | |
| Q3 FY24 | 286.8K | +38% | |
| Q2 FY24 | 203.5K | −3% | |
| Q1 FY24 | 191.1K | −9% | |
| Q4 FY23 | 193.4K | −8% | |
| Q3 FY23 | 207.3K | +55% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Silo Pharma
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.